Cargando…
156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106941/ http://dx.doi.org/10.1016/j.jid.2023.03.157 |
| _version_ | 1785026512065396736 |
|---|---|
| author | Pira, A. Mariotti, F. Moro, F. Panebianco, A. Pallotta, S. Didona, B. Di Zenzo, G. |
| author_facet | Pira, A. Mariotti, F. Moro, F. Panebianco, A. Pallotta, S. Didona, B. Di Zenzo, G. |
| author_sort | Pira, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10106941 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101069412023-04-17 156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset Pira, A. Mariotti, F. Moro, F. Panebianco, A. Pallotta, S. Didona, B. Di Zenzo, G. J Invest Dermatol Article Published by Elsevier Inc. 2023-05 2023-04-17 /pmc/articles/PMC10106941/ http://dx.doi.org/10.1016/j.jid.2023.03.157 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Pira, A. Mariotti, F. Moro, F. Panebianco, A. Pallotta, S. Didona, B. Di Zenzo, G. 156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset |
| title | 156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset |
| title_full | 156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset |
| title_fullStr | 156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset |
| title_full_unstemmed | 156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset |
| title_short | 156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset |
| title_sort | 156 covid-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106941/ http://dx.doi.org/10.1016/j.jid.2023.03.157 |
| work_keys_str_mv | AT piraa 156covid19vaccineisariskfactoracceleratingtimetobullouspemphigoidonset AT mariottif 156covid19vaccineisariskfactoracceleratingtimetobullouspemphigoidonset AT morof 156covid19vaccineisariskfactoracceleratingtimetobullouspemphigoidonset AT panebiancoa 156covid19vaccineisariskfactoracceleratingtimetobullouspemphigoidonset AT pallottas 156covid19vaccineisariskfactoracceleratingtimetobullouspemphigoidonset AT didonab 156covid19vaccineisariskfactoracceleratingtimetobullouspemphigoidonset AT dizenzog 156covid19vaccineisariskfactoracceleratingtimetobullouspemphigoidonset |